Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study
Abstract Hepatic fibrosis is the net accumulation of matrix tissue components which controlled by pro-fibrolytic enzymes, matrix metalloproteinases (MMPs), and pro-fibrotic cytokine, TGF-β1, and enzymes, tissue inhibitors of MMPs (TIMPs). Vitamin D (VD) supplementation has been shown to reverse thes...
Main Authors: | Piyawat Komolmit, Sayamon Kimtrakool, Sirinporn Suksawatamnuay, Kessarin Thanapirom, Kanita Chattrasophon, Panarat Thaimai, Chintana Chirathaworn, Yong Poovorawan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-09512-7 |
Similar Items
-
Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial.
by: Piyawat Komolmit, et al.
Published: (2017-01-01) -
Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C
by: Kessarin Thanapirom, et al.
Published: (2019-09-01) -
Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients
by: Kessarin Thanapirom, et al.
Published: (2017-04-01) -
Stability of hepatitis B virus pregenomic RNA in plasma specimens under various temperatures and storage conditions
by: Pakkapon Rattanachaisit, et al.
Published: (2021-04-01) -
Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial
by: Supachaya Sriphoosanaphan, et al.
Published: (2021-02-01)